Clinical Trial Update: A Study to Investigate the Effects of Imatinib on Pulmonary Vascular Dysfunction in a Human Model of Lung Injury [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the effects of imatinib on pulmonary vascular dysfunction in a human model of acute lung injury has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Exvastat Ltd. | Conditions: Acute Lung Injury | Phase 1 | Status: COMPLETED